[S100A4 may serve as a biomarker for progression of ESCC and a potential molecular target for biotherapy of ESCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE